Zoon Kathryn C
SEC insider (Form 3/4/5 filer). CIK 0001685720. Director at Emergent BioSolutions Inc. (EBS). 6 reported Form 4/5 transactions since Sep 2024; latest on May 1, 2026. Located in GAITHERSBURG, MD.
Companies Zoon Kathryn C has filed insider reports for
- Emergent BioSolutions Inc. (EBS): Director
Zoon Kathryn C
CIK: 0001685720
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EBS
Emergent BioSolutions Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 1, 2026EBS
Emergent BioSolutions Inc.
SaleDirect16.1K shares at avg. $8.36$135K - May 1, 2026EBS
Emergent BioSolutions Inc.
SaleDirect1.1K shares at avg. $8.97$9K - Apr 30, 2026EBS
Emergent BioSolutions Inc.
AwardDirect25.3K shares- - Aug 15, 2025EBS
Emergent BioSolutions Inc.
SaleDirect7.1K shares at avg. $8.87$63K - Apr 30, 2025EBS
Emergent BioSolutions Inc.
AwardDirect34.4K shares- - Mar 12, 2025EBS
Emergent BioSolutions Inc.
SaleDirect10K shares at avg. $5.73$57K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 1, 2026 | EBS Emergent BioSolutions Inc. | Sale | 16,145 | $8.36 | $134,972 | Direct |
| May 1, 2026 | EBS Emergent BioSolutions Inc. | Sale | 1,057 | $8.97 | $9,481 | Direct |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | Award | 25,344 | - | $0 | Direct |
| Aug 15, 2025 | EBS Emergent BioSolutions Inc. | Sale | 7,086 | $8.87 | $62,853 | Direct |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | Award | 34,403 | - | - | Direct |
| Mar 12, 2025 | EBS Emergent BioSolutions Inc. | Sale | 10,000 | $5.73 | $57,300 | Direct |
1-6 of 6 transactions